Synthesis and biological activities of new hydrazide derivatives

被引:53
作者
Ozdemir, Ahmet [1 ]
Turan-Zitouni, Gulhan [1 ]
Kaplancikli, Zafer Asim [1 ]
Tunali, Yagmur [2 ]
机构
[1] Anadolu Univ, Fac Pharm, Dept Pharmaceut Chem, TR-26470 Eskisehir, Turkey
[2] Anadolu Univ, Fac Pharm, Dept Microbiol, TR-26470 Eskisehir, Turkey
关键词
Hydrazide; imidazo[1,2-a]pyrazine; antimicrobial activity; antituberculosis activity; ANTIMICROBIAL ACTIVITY; MYCOBACTERIUM-TUBERCULOSIS; HETEROCYCLIC-COMPOUNDS; IN-VITRO; HYDRAZONES; CYTOCHROME-P450; ACID;
D O I
10.1080/14756360802399712
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The synthesis of a new series of imidazo[1,2-a]pyrazine-2-carboxylic acid arylidene-hydrazides is described. The chemical structures of the compounds were elucidated by IR, H-1-NMR, FAB(+)-MS spectral data. Their biological activity against various bacteria, fungi species, and Mycobacterium tuberculosis was investigated. Antibacterial activity was measured against Escherichia coli (NRRL B-3704), Staphylococcus aureus (NRRL B-767), Salmonella typhimurium (NRRL B-4420), Proteus vulgaris (NRLL B-123), Enterococcus faecalis (isolated obtained from Faculty of Medicine Osmangazi University, Eskisehir, Turkey), Pseudomonas aeruginosa (NRRL B-23 27853), Klebsiella spp. (isolated obtained from Faculty of Medicine Osmangazi University, Eskisehir, Turkey), while antifungal activity was evaluated against Candida albicans (isolates obtained from Osmangazi Uni. Fac. of Medicine), Candida glabrata (isolates obtained from Osmangazi Uni. Fac. of Medicine). Compounds were also evaluated for antituberculosis activity against Mycobacterium tuberculosis H(37)Rv using the BACTEC 460 radiometric system and BACTEC 12B medium. The compounds showed moderate inhibitor effects against human pathogenic microorganisms., whereas the preliminary results indicated that all of the tested compounds were inactive against Mycobacterium tuberculosis H(37)Rv.
引用
收藏
页码:825 / 831
页数:7
相关论文
共 29 条
[1]  
ABIGNENTE E, 1981, FARMACO-ED SCI, V36, P61
[2]   Antifungal resistance trends towards the year 2000 - Implications for therapy and new approaches [J].
Alexander, BD ;
Perfect, JR .
DRUGS, 1997, 54 (05) :657-678
[3]  
[Anonymous], 2002, Reference method for broth dilution antifungal susceptibility testing of yeasts, V2nd
[4]   MYCOBACTERIUM-TUBERCULOSIS AND MYCOBACTERIUM-AVIUM COMPLEX DISEASE IN PATIENTS WITH HIV-INFECTION [J].
BENSON, CA .
CURRENT OPINION IN INFECTIOUS DISEASES, 1994, 7 (01) :95-107
[5]  
BONNET PA, 1983, EUR J MED CHEM, V18, P413
[6]  
Churchyard GJ, 2000, S AFR MED J, V90, P472
[7]   Microplate Alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium [J].
Collins, LA ;
Franzblau, SG .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (05) :1004-1009
[8]   Azole-antifungal binding to a novel cytochrome P450 from Mycobacterium tuberculosis:: implications for treatment of tuberculosis [J].
Guardiola-Diaz, HM ;
Foster, LA ;
Mushrush, D ;
Vaz, ADN .
BIOCHEMICAL PHARMACOLOGY, 2001, 61 (12) :1463-1470
[9]   Synthesis of some new hydrazide-hydrazones, thiosemicarbazides and thiazolidinones as possible antimicrobials [J].
Gursoy, A ;
Terzioglu, N ;
Otuk, G .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1997, 32 (09) :753-757
[10]   Treatment of fungal infection in AIDS [J].
Hood, S ;
Denning, DW .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 37 :71-85